Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014', provides an overview of the Hisamitsu Pharmaceutical Co., Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hisamitsu Pharmaceutical Co., Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Hisamitsu Pharmaceutical Co., Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Hisamitsu Pharmaceutical Co., Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Hisamitsu Pharmaceutical Co., Inc.'s pipeline products

Reasons to buy

- Evaluate Hisamitsu Pharmaceutical Co., Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Hisamitsu Pharmaceutical Co., Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Hisamitsu Pharmaceutical Co., Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Hisamitsu Pharmaceutical Co., Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hisamitsu Pharmaceutical Co., Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Hisamitsu Pharmaceutical Co., Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Hisamitsu Pharmaceutical Co., Inc. Snapshot 5
Hisamitsu Pharmaceutical Co., Inc. Overview 5
Key Information 5
Key Facts 5
Hisamitsu Pharmaceutical Co., Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Hisamitsu Pharmaceutical Co., Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products Glance 12
Hisamitsu Pharmaceutical Co., Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Hisamitsu Pharmaceutical Co., Inc. - Drug Profiles 14
dextroamphetamine 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
HP-3060 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ropinirole hydrochloride 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
HP-3070 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Hisamitsu Pharmaceutical Co., Inc. - Pipeline Analysis 18
Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Target 18
Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Route of Administration 19
Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Molecule Type 20
Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Mechanism of Action 21
Hisamitsu Pharmaceutical Co., Inc. - Recent Pipeline Updates 22
Hisamitsu Pharmaceutical Co., Inc. - Dormant Projects 23
Hisamitsu Pharmaceutical Co., Inc. - Discontinued Pipeline Products 24
Discontinued Pipeline Product Profiles 24
ketoprofen patch 24
Hisamitsu Pharmaceutical Co., Inc. - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28

List of Tables
Hisamitsu Pharmaceutical Co., Inc., Key Information 5
Hisamitsu Pharmaceutical Co., Inc., Key Facts 5
Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Indication, 2014 7
Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Stage of Development, 2014 8
Hisamitsu Pharmaceutical Co., Inc. - Monotherapy Products in Pipeline, 2014 9
Hisamitsu Pharmaceutical Co., Inc. - Partnered Products in Pipeline, 2014 10
Hisamitsu Pharmaceutical Co., Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11
Hisamitsu Pharmaceutical Co., Inc. - Phase II, 2014 12
Hisamitsu Pharmaceutical Co., Inc. - Phase I, 2014 13
Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Target, 2014 18
Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Route of Administration, 2014 19
Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Molecule Type, 2014 20
Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Mechanism of Action, 2014 21
Hisamitsu Pharmaceutical Co., Inc. - Recent Pipeline Updates, 2014 22
Hisamitsu Pharmaceutical Co., Inc. - Dormant Developmental Projects,2014 23
Hisamitsu Pharmaceutical Co., Inc. - Discontinued Pipeline Products, 2014 24
Hisamitsu Pharmaceutical Co., Inc., Other Locations 25
Hisamitsu Pharmaceutical Co., Inc., Subsidiaries 26